Dominant Combined Immunodeficiency Associated With A Heterozygous Intragenic Deletion In Irf4.

J. Brozyna,T. Hwangpo,A. Hurst,H. Schroeder,T. Atkinson
DOI: https://doi.org/10.1016/j.anai.2024.08.701
2024-10-27
Abstract:Introduction Interferon regulatory factor-4 (IRF4) is a transcription factor restricted to hematopoietic immune cells. It is induced by a range of mitogenic stimuli including T and B cell receptor signaling as well as Toll-like receptor activation and CD40 signaling pathways, and has functions important for adaptive immune responses. Case Description A commercial panel of primary immunodeficiency genes revealed a novel mutation in a gene that was fully penetrant in multiple family members over three generations in a large multiplex kindred. Affected family members were found to carry a deletion in exon 7 of the IRF4 gene resulting in an in-frame 117 amino acid deletion comprising part of the IRF association domain, which mediates protein-protein interactions. The affected patients have a variable phenotype of autoimmunity and humoral immunodeficiency that ranges from agammaglobulinemia to low IgM with poor antibody responses to pneumococcal polysaccharides. Flow cytometry abnormalities include reduced CD62L+ CD45RA+ T cells for age and often borderline-to-low CD8+ T cells. Discussion Dominant negative IRF4 deficiency has been previously described in two publications (p.T95R and p.F359L) with multimorphic effects on IRF4 binding partners. Patients suffered from recurrent respiratory tract infections including with opportunistic organisms, hypogammaglobulinemia, impaired formation of plasma cells and low naïve T cell counts. Dominantly inherited mutations affecting the IRF4 association domain can present primarily as a humoral immunodeficiency resembling agammaglobulinemia, Common Variable Immunodeficiency or specific antibody deficiency and give insight into the mechanism of this inborn error of immunity.
immunology,allergy
What problem does this paper attempt to address?